As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption.
SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been selected for Phase 1 of a next-generation vaccine development initiative ...
Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative for Precision Medicine LeadersDelray Beach, FL, Feb. 24, 2026 (GLOBE ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research WALTHAM, Mass.--(BUSINESS WIRE) ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results